Symptoms of depression and heavy alcohol use interact to lower the chances of achieving virologic suppression in people with HIV infection.
NeuroRx announced that the FDA has granted Breakthrough Therapy designation to NRX-101 for the treatment of severe bipolar depression with acute suicidal ideation.
Investigators examine whether parental mental disorders directly affect offspring's work disability in early adulthood or if they are attributed to offspring's own mental disorders and social disadvantages.
Mark Zimmerman, MD, discusses controversies related to categorizing severity and identifying optimal treatment of depression.
Emerging research is leading to new theories attempting to address why a significant number of individuals with major depressive disorder do not achieve relief of their symptoms after receiving treatment.
Intranasal esketamine in combination with oral antidepressants demonstrated significant reduction of depressive symptoms and improved overall severity of depressive illness and health-related quality of life and functioning.
Bupropion had a greater effect on reducing impulsivity and attention symptoms than escitalopram.
Investigators analyzed the differences in hospitalization outcomes, comorbidities, and utilization of procedures in patients with PD vs patients with PD and MDD.
This finding suggests an adverse effect of hormonal contraception on psychological health in adolescent girls.
Suicidal thinking may influence affect in a reinforcing manner, partially explaining its persistent nature in subsets of patients.
Nightmares are frequently comorbid with other sleep and mental health disorders in US military personnel.
A peer-to-peer depression awareness program improves knowledge and attitudes about depression among high school students.
Risk factors for poor sleep in menopause include depression and vasomotor symptoms.
One reason selective serotonin reuptake inhibitors may affect the likelihood of osteoporosis is that the drug antagonizes the serotonin transporter, 5-HTT.
Flibanserin can be safely added to a stable SSRI or SNRI regimen to treat hypoactive sexual desire disorder.
The independent association between anhedonia and suicidal ideation may improve detection of suicide risks and encourage new suicide depression strategies.
In patients with major depressive disorder, moderate to severe obstructive sleep apnea is common.
Many factors may be associated with the development of postpartum depression such as gestational age, BMI, Apgar scores, mode of delivery, and exposure to anesthesia.
In patients diagnosed with sarcoma, poor QoL, depression, and anxiety are common.
Depressive Symptoms Decreased When Using Treatment Methods Increasing Resilience for Hidradenitis SuppurativaJanuary 03, 2018
In managing and treating HS, the methods that increase resilience may help decrease depressive symptoms.
Single-question self-assessment is not a sufficient marker of identifying depression in people with IBD.
Treatment with biologic agents in psoriasis may reduce risk for depressive symptoms.
Suicide in prisons is multifactorial, with contributing factors that include medical and mental health issues as well as those involving family, lack of purposeful activity, and conditions of the specific prison environment, as well as the stress of adjusting to incarceration.
Cognitive behavioral therapy combined with antidepressant medication modestly improves psychosocial outcomes.
Minocycline has a large antidepressant effect and good tolerability compared with placebo.
Smartphone and tracking devices can equip clinicians with a better understanding of mood states and behavior.
Depressive symptoms in patients with intellectual disabilities were decreased equally by 2 distinct interventions.
Frequent cannabis users experience more pain and negative affects than less- frequent users.
Family members of ALS patients have higher rates of neuropsychiatric conditions.
Patients with frequent migraines were shown to have an increased risk for depression and anxiety.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- Minocycline vs Routine Care for Clinical Symptom Improvement in Schizophrenia
- Insomnia in Borderline Personality Disorder May Increase Suicide Risk
- FDA Approves Powerful New Opioid Despite Criticisms
- Heart Rate Variability Predicts Treatment Response in Anxious Depression
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Psychotropic Medication May Reduce Symptoms and Improve Functioning in PTSD
- Social Decline a Predictor of Conversion Outcome in High-Risk Individuals
- Buprenorphine/Samidorphan Helpful in Refractory Depression